View Future GrowthScientex Berhad 過去の業績過去 基準チェック /56Scientex Berhadは、平均年間5.5%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間0.4% 5.3%収益成長率で 成長しています。 Scientex Berhadの自己資本利益率は13.1%であり、純利益率は12.1%です。主要情報5.54%収益成長率5.46%EPS成長率Chemicals 業界の成長8.86%収益成長率5.28%株主資本利益率13.10%ネット・マージン12.11%前回の決算情報31 Jan 2026最近の業績更新Reported Earnings • Mar 14Second quarter 2026 earnings released: EPS: RM0.087 (vs RM0.08 in 2Q 2025)Second quarter 2026 results: EPS: RM0.087 (up from RM0.08 in 2Q 2025). Revenue: RM1.14b (up 2.8% from 2Q 2025). Net income: RM135.2m (up 9.1% from 2Q 2025). Profit margin: 12% (in line with 2Q 2025). Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 23Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 2.7%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Reported Earnings • Sep 18Full year 2025 earnings released: EPS: RM0.34 (vs RM0.35 in FY 2024)Full year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 19Third quarter 2025 earnings released: EPS: RM0.08 (vs RM0.084 in 3Q 2024)Third quarter 2025 results: EPS: RM0.08 (down from RM0.084 in 3Q 2024). Revenue: RM1.11b (flat on 3Q 2024). Net income: RM123.9m (down 5.1% from 3Q 2024). Profit margin: 11% (in line with 3Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 13Second quarter 2025 earnings released: EPS: RM0.08 (vs RM0.091 in 2Q 2024)Second quarter 2025 results: EPS: RM0.08 (down from RM0.091 in 2Q 2024). Revenue: RM1.11b (up 1.1% from 2Q 2024). Net income: RM123.9m (down 12% from 2Q 2024). Profit margin: 11% (down from 13% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 24Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.すべての更新を表示Recent updates分析記事 • May 15Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of InvestorsThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Reported Earnings • Mar 14Second quarter 2026 earnings released: EPS: RM0.087 (vs RM0.08 in 2Q 2025)Second quarter 2026 results: EPS: RM0.087 (up from RM0.08 in 2Q 2025). Revenue: RM1.14b (up 2.8% from 2Q 2025). Net income: RM135.2m (up 9.1% from 2Q 2025). Profit margin: 12% (in line with 2Q 2025). Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Dec 31Upcoming dividend of RM0.06 per shareEligible shareholders must have bought the stock before 07 January 2026. Payment date: 23 January 2026. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of Malaysian dividend payers (5.5%). In line with average of industry peers (3.4%).分析記事 • Dec 29Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the...分析記事 • Dec 15Scientex Berhad's (KLSE:SCIENTX) Dividend Will Be MYR0.06Scientex Berhad ( KLSE:SCIENTX ) will pay a dividend of MYR0.06 on the 23rd of January. This payment means that the...Reported Earnings • Nov 23Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 2.7%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.分析記事 • Nov 17Scientex Berhad's (KLSE:SCIENTX) Dividend Will Be MYR0.06Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the 23rd of January...お知らせ • Nov 17Scientex Berhad, Annual General Meeting, Dec 17, 2025Scientex Berhad, Annual General Meeting, Dec 17, 2025, at 11:30 Singapore Standard Time. Location: scientex packaging film sdn bhd, lot 4, jalan sungai pinang 4/3, seksyen 4, taman perindustrian pulau indah, 42920 pelabuhan klang, selangor darul ehsan, Malaysia分析記事 • Sep 19Scientex Berhad (KLSE:SCIENTX) Is Due To Pay A Dividend Of MYR0.06Scientex Berhad ( KLSE:SCIENTX ) will pay a dividend of MYR0.06 on the 23rd of January. This payment means that the...Declared Dividend • Sep 19Final dividend of RM0.06 announcedDividend of RM0.06 is the same as last year. Ex-date: 7th January 2026 Payment date: 23rd January 2026 Dividend yield will be 3.4%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 21% over the next 3 years, which should provide support to the dividend and adequate earnings cover.分析記事 • Sep 18Investors Could Be Concerned With Scientex Berhad's (KLSE:SCIENTX) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Reported Earnings • Sep 18Full year 2025 earnings released: EPS: RM0.34 (vs RM0.35 in FY 2024)Full year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • Sep 18+ 1 more updateScientex Berhad Appoints Puan Sabarina Binti Harun as Independent and Non Executive Independent Director, Effective September 17, 2025Scientex Berhad announced the appointment of PUAN SABARINA BINTI HARUN as Independent and Non Executive Independent Director. Age 48, date of change September 17, 2025. Qualifications Others Finance and Accounting Universiti Geomatika Malaysia Adjunct Professor Professional Qualification Accounting ASEAN Chartered Professional Accountant Professional Qualification Project Management Professional Project Management Institute Professional Qualification Accounting Malaysian Institute of Accountants Chartered Accountant (CA) Professional Qualification Accounting Certified Practising Accountant (CPA) Australia Fellow CPA (FCPA) Degree Bachelor of Commerce La Trobe University, Australia Working experience and occupation Mrs. Sabarina Binti Harun has more than twenty-five (25) years of experience in strategy development, financial management, digital transformation and operations. She has solid change management experience in her various positions, proven track record in managing cross-functional teams, implementing successful, robust and efficient operational processes for organisational change. Prior to joining SIRIM Berhad, Mrs. Sabarina was the Group Financial Controller to Inai Kiara Group of Companies, which is the fifth largest dredging company in the world. She started her career with Inai Kiara as the Financial Controller for the holding company, orchestrating a prominent impact in three (3) different portfolios namely finance, quality management and project management. She then joined SIRIM Berhad as the Group Chief Finance Officer to spearhead the overall financial operations, growth and strategies, asset management and procurement activities of SIRIM Berhad and its subsidiaries ("SIRIM Group"). She is currently the Group Chief Operating Officer at SIRIM Berhad, leading the Project Monitoring Office and Digital Services for SIRIM Group, overseeing the asset management and operations of ten (10) State offices nationwide and lead two (2) Strategic Business Units of SIRIM Group under the developmental and commercial mandates. Presently, she sits on the Board of Directors of Redtone Digital Berhad and DSR Taiko Berhad as an Independent Non-Executive Director. She is also a member of the Audit Committee and Nomination Committee of Redtone Digital Berhad; and Chairperson of the Audit Committee of DSR Taiko Berhad.分析記事 • Jul 21Earnings Working Against Scientex Berhad's (KLSE:SCIENTX) Share PriceScientex Berhad's ( KLSE:SCIENTX ) price-to-earnings (or "P/E") ratio of 9.5x might make it look like a buy right now...分析記事 • Jun 20Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.06Scientex Berhad's ( KLSE:SCIENTX ) investors are due to receive a payment of MYR0.06 per share on 18th of July. This...Declared Dividend • Jun 20Dividend of RM0.06 announcedDividend of RM0.06 is the same as last year. Ex-date: 7th July 2025 Payment date: 18th July 2025 Dividend yield will be 3.5%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (34% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 17% over the next 2 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 19Scientex Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 31 July 2025, Payable on 18 July 2025In respect of the financial year ending 31 July 2025, the Board of Directors of Scientex Berhad declared a single tier interim dividend of 6 sen per ordinary share (single tier interim dividend for financial year 2024 of 6 sen per ordinary share), payable on 18 July 2025.New Risk • Jun 19New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 44% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (44% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Reported Earnings • Jun 19Third quarter 2025 earnings released: EPS: RM0.08 (vs RM0.084 in 3Q 2024)Third quarter 2025 results: EPS: RM0.08 (down from RM0.084 in 3Q 2024). Revenue: RM1.11b (flat on 3Q 2024). Net income: RM123.9m (down 5.1% from 3Q 2024). Profit margin: 11% (in line with 3Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.分析記事 • May 23Scientex Berhad (KLSE:SCIENTX) Could Be Struggling To Allocate CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...分析記事 • Apr 29We Think Scientex Berhad (KLSE:SCIENTX) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...分析記事 • Apr 02Improved Earnings Required Before Scientex Berhad (KLSE:SCIENTX) Shares Find Their FeetWhen close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") above 15x, you may consider...Price Target Changed • Mar 13Price target decreased by 9.8% to RM4.19Down from RM4.65, the current price target is an average from 7 analysts. New target price is 19% above last closing price of RM3.53. Stock is down 8.5% over the past year. The company is forecast to post earnings per share of RM0.35 for next year compared to RM0.35 last year.Reported Earnings • Mar 13Second quarter 2025 earnings released: EPS: RM0.08 (vs RM0.091 in 2Q 2024)Second quarter 2025 results: EPS: RM0.08 (down from RM0.091 in 2Q 2024). Revenue: RM1.11b (up 1.1% from 2Q 2024). Net income: RM123.9m (down 12% from 2Q 2024). Profit margin: 11% (down from 13% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Mar 12+ 4 more updatesScientex Berhad Announces Redesignation of Lim Peng Cheong as Chairman from Non-Independent DirectorScientex Berhad announced redesignation of Mr. Lim Peng Cheong as Chairman from Non-Independent Director. Age is 62 years. Directorate is Non Independent and Non Executive. Date of change is 12 March 2025. He did Bachelor of Science (Honours) in Business Studies from City University, UK. Working experience and occupation includes Mr. Lim Peng Cheong was appointed to the Board of Scientex Berhad as an Executive Director on 9 September 1988, and has held this position until 10 November 2003, when he was re-designated as Non-Executive Director. He was the Managing Director of Malacca Securities Sdn Bhd and was re-designated as Executive Chairman on 1 August 2021.分析記事 • Jan 15Calculating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)Key Insights Scientex Berhad's estimated fair value is RM4.19 based on 2 Stage Free Cash Flow to Equity With RM4.01...分析記事 • Jan 02Investors Met With Slowing Returns on Capital At Scientex Berhad (KLSE:SCIENTX)If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Upcoming Dividend • Dec 31Upcoming dividend of RM0.06 per shareEligible shareholders must have bought the stock before 07 January 2025. Payment date: 17 January 2025. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of Malaysian dividend payers (5.1%). Higher than average of industry peers (2.2%).分析記事 • Dec 17Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the...分析記事 • Nov 25Is Scientex Berhad (KLSE:SCIENTX) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Nov 24Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Nov 18Scientex Berhad, Annual General Meeting, Dec 18, 2024Scientex Berhad, Annual General Meeting, Dec 18, 2024, at 11:30 Singapore Standard Time.分析記事 • Nov 05We Ran A Stock Scan For Earnings Growth And Scientex Berhad (KLSE:SCIENTX) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...分析記事 • Sep 30Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06Scientex Berhad's ( KLSE:SCIENTX ) investors are due to receive a payment of MYR0.06 per share on 17th of January. This...分析記事 • Sep 26Analysts Are Updating Their Scientex Berhad (KLSE:SCIENTX) Estimates After Its Annual ResultsIt's been a good week for Scientex Berhad ( KLSE:SCIENTX ) shareholders, because the company has just released its...Declared Dividend • Sep 26Final dividend of RM0.06 announcedShareholders will receive a dividend of RM0.06. Ex-date: 7th January 2025 Payment date: 17th January 2025 Dividend yield will be 2.8%, which is lower than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (24% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Sep 25Full year 2024 earnings released: EPS: RM0.35 (vs RM0.28 in FY 2023)Full year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.分析記事 • Sep 09Scientex Berhad (KLSE:SCIENTX) Is Looking To Continue Growing Its Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...分析記事 • Aug 06Scientex Berhad (KLSE:SCIENTX) Ticks All The Boxes When It Comes To Earnings GrowthFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...分析記事 • Jun 25Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts ThinkScientex Berhad ( KLSE:SCIENTX ) came out with its first-quarter results last week, and we wanted to see how the...Price Target Changed • Jun 25Price target increased by 8.3% to RM4.51Up from RM4.16, the current price target is an average from 7 analysts. New target price is 5.8% above last closing price of RM4.26. Stock is up 26% over the past year. The company is forecast to post earnings per share of RM0.35 for next year compared to RM0.28 last year.分析記事 • Jun 24Scientex Berhad (KLSE:SCIENTX) Is Increasing Its Dividend To MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will be paying its dividend of MYR0.06 on the 19th...Declared Dividend • Jun 24Dividend increased to RM0.06Dividend of RM0.06 is 20% higher than last year. Ex-date: 9th July 2024 Payment date: 19th July 2024 Dividend yield will be 2.6%, which is lower than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 18% over the next 2 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Jun 22Third quarter 2024 earnings released: EPS: RM0.084 (vs RM0.071 in 3Q 2023)Third quarter 2024 results: EPS: RM0.084 (up from RM0.071 in 3Q 2023). Revenue: RM1.11b (up 11% from 3Q 2023). Net income: RM130.5m (up 19% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.お知らせ • Jun 21Scientex Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 31 July 2024, Payable on 19 July 2024Scientex Berhad announced Single Tier Interim Dividend of 6 sen per ordinary share, for the Financial Year Ending 31 July 2024. Ex-Date: 09 July 2024; Entitlement date: 10 July 2024. Payment Date: 19 July 2024.分析記事 • Mar 28Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen NextInvestors in Scientex Berhad ( KLSE:SCIENTX ) had a good week, as its shares rose 8.1% to close at RM4.13 following the...分析記事 • Mar 27Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of InvestorsIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Mar 27Second quarter 2024 earnings released: EPS: RM0.091 (vs RM0.069 in 2Q 2023)Second quarter 2024 results: EPS: RM0.091 (up from RM0.069 in 2Q 2023). Revenue: RM1.09b (up 12% from 2Q 2023). Net income: RM141.0m (up 33% from 2Q 2023). Profit margin: 13% (up from 11% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 1% per year.Upcoming Dividend • Dec 26Upcoming dividend of RM0.05 per share at 0.3% yieldEligible shareholders must have bought the stock before 02 January 2024. Payment date: 26 January 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (2.9%).お知らせ • Dec 14+ 4 more updatesScientex Berhad Appoints Chin Lam Choong as Independent and Non Executive Chairman of Nomination and Remuneration Committee and Member of Audit Committee and Risk CommitteeScientex Berhad announced the appointment of Mr. Chin Lam Choong as Independent and Non Executive Chairman of Nomination and Remuneration Committee and Member of Audit Committee and Risk Committee of the company. Age: 57. Date of change: December 14, 2023. Composition of Audit Committee (Name and Directorate of members after change): change): Mr. Wong Chin Mun (Senior Independent Non-Executive Director) – Chairman; Dato' Noorizah Binti Hj Abd Hamid (Independent Non-Executive Director) – Member; Mr. Chin Lam Choong (Independent Non-Executive Director) – Member. Composition of Nomination and Remuneration Committee (Name and Directorate of members after change): Mr. Chin Lam Choong (Independent Non-Executive Director) - Chairman; Mr. Wong Chin Mun (Senior Independent Non-Executive Director) - Member; Mr. Lim Peng Cheong (Non-Independent Non-Executive Director) - Member. Composition of Risk Committee (Name and Directorate of members after change): Dato' Noorizah Binti Hj Abd Hamid (Independent Non-Executive Director) - Chairperson; Mr. Lim Peng Jin (Managing Director/Chief Executive Officer) - Member; Mr. Chin Lam Choong (Independent Non-Executive Director) - Member.Reported Earnings • Nov 17Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: RM0.28 (up from RM0.26 in FY 2022). Revenue: RM4.08b (up 2.3% from FY 2022). Net income: RM438.1m (up 6.9% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 5.8%. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 4% per year.お知らせ • Nov 15Scientex Berhad, Annual General Meeting, Dec 14, 2023Scientex Berhad, Annual General Meeting, Dec 14, 2023, at 11:30 Singapore Standard Time. Location: Auditorium, Bangunan Scientex, No. 9, Persiaran Selangor, Seksyen 15, 40200 Shah Alam Darul Ehsan Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 July 2023 together with the Reports of the Directors and Auditors thereon; to declare a single tier final dividend of 5 sen per ordinary share in respect of the financial year ended 31 July 2023; to re-elect Chin Lam Choong who retire by rotation in accordance with Regulation 87 of the Company's Constitution and being eligible, has offered himself for re-election; and to consider other matters.分析記事 • Sep 23An Intrinsic Calculation For Scientex Berhad (KLSE:SCIENTX) Suggests It's 30% UndervaluedKey Insights The projected fair value for Scientex Berhad is RM5.35 based on 2 Stage Free Cash Flow to Equity Scientex...分析記事 • Sep 22Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.05 per share on the...お知らせ • Sep 21Scientex Berhad Declares A Single Tier Final Dividend for the Financial Ended July 31, 2023, Payable on January 26, 2024Scientex Berhad declared a single tier final dividend of MYR 0.0500 per ordinary share for the Financial ended July 31, 2023, payable on January 26, 2024. Ex-Date: January 2, 2024. Entitlement date: January 2, 2024.Reported Earnings • Sep 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: RM0.28 (up from RM0.26 in FY 2022). Revenue: RM4.08b (up 2.3% from FY 2022). Net income: RM438.1m (up 6.9% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 5.8%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.Upcoming Dividend • Jun 28Upcoming dividend of RM0.05 per share at 2.9% yieldEligible shareholders must have bought the stock before 05 July 2023. Payment date: 21 July 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Malaysian dividend payers (5.5%). Lower than average of industry peers (6.3%).分析記事 • Jun 26Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Larger Dividend Than Last YearScientex Berhad ( KLSE:SCIENTX ) has announced that it will be increasing its dividend from last year's comparable...Reported Earnings • Jun 21Third quarter 2023 earnings released: EPS: RM0.071 (vs RM0.057 in 3Q 2022)Third quarter 2023 results: EPS: RM0.071 (up from RM0.057 in 3Q 2022). Revenue: RM997.1m (flat on 3Q 2022). Net income: RM109.8m (up 24% from 3Q 2022). Profit margin: 11% (up from 8.9% in 3Q 2022). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 4% per year.分析記事 • May 11Estimating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)Key Insights Scientex Berhad's estimated fair value is RM3.90 based on 2 Stage Free Cash Flow to Equity Scientex...Reported Earnings • Mar 16Second quarter 2023 earnings released: EPS: RM0.069 (vs RM0.06 in 2Q 2022)Second quarter 2023 results: EPS: RM0.069 (up from RM0.06 in 2Q 2022). Revenue: RM978.4m (up 2.8% from 2Q 2022). Net income: RM106.3m (up 14% from 2Q 2022). Profit margin: 11% (up from 9.8% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 01Scientex Berhad Appoints Chua Siew Chuan as Joint Secretary, Effective February 1, 2023Scientex Berhad announced the appointment of Chua Siew Chuan as Joint Secretary of the company, with effect from February 1, 2023.分析記事 • Jan 27Scientex Berhad (KLSE:SCIENTX) May Have Issues Allocating Its CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Upcoming Dividend • Dec 16Upcoming dividend of RM0.05 per shareEligible shareholders must have bought the stock before 23 December 2022. Payment date: 09 January 2023. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (5.7%).Reported Earnings • Dec 10First quarter 2023 earnings released: EPS: RM0.069 (vs RM0.066 in 1Q 2022)First quarter 2023 results: EPS: RM0.069 (up from RM0.066 in 1Q 2022). Revenue: RM1.03b (up 11% from 1Q 2022). Net income: RM107.2m (up 4.2% from 1Q 2022). Profit margin: 10% (in line with 1Q 2022). Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.分析記事 • Dec 09Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.05 per share on the 9th...お知らせ • Dec 09Scientex Berhad Approves the Declaration of Single Tier Final DividendScientex Berhad approved the declaration of a single tier final dividend of 5 sen per ordinary share, at its AGM held on 8 December 2022.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Richard Wong was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 10Scientex Berhad, Annual General Meeting, Dec 08, 2022Scientex Berhad, Annual General Meeting, Dec 08, 2022, at 11:30 Singapore Standard Time. Location: Auditorium, Bangunan Scientex, No. 9, Persiaran Selangor, Seksyen 15 Shah Alam Selangor Malaysia Agenda: To approve the declaration of a single tier final dividend of 5 sen per ordinary share; to consider re-election of directors; to re-appoint Deloitte PLT as the Auditors of the Company and to authorise the Directors to fix their remuneration; and to consider other matters.分析記事 • Oct 02Scientex Berhad (KLSE:SCIENTX) Has Affirmed Its Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend on the 9th of January, with...Reported Earnings • Sep 30Full year 2022 earnings released: EPS: RM0.26 (vs RM0.29 in FY 2021)Full year 2022 results: EPS: RM0.26 (down from RM0.29 in FY 2021). Revenue: RM3.99b (up 9.0% from FY 2021). Net income: RM409.9m (down 10% from FY 2021). Profit margin: 10% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Malaysia are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.お知らせ • Sep 29Scientex Berhad Declares Single Tier Final Dividend for the Financial Ended July 31, 2022, Payable on January 09, 2023Scientex Berhad declared a single tier final dividend of MYR 0.0500 per ordinary share for the Financial ended July 31, 2022, payable on January 09, 2023. Ex-Date: December 23, 2022. Entitlement date: December 27, 2022.分析記事 • Sep 23Scientex Berhad (KLSE:SCIENTX) Shares Could Be 35% Below Their Intrinsic Value EstimateHow far off is Scientex Berhad ( KLSE:SCIENTX ) from its intrinsic value? Using the most recent financial data, we'll...分析記事 • Sep 08Here's Why Scientex Berhad (KLSE:SCIENTX) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...分析記事 • Jul 13Here's What's Concerning About Scientex Berhad's (KLSE:SCIENTX) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Upcoming Dividend • Jun 30Upcoming dividend of RM0.04 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 22 July 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Malaysian dividend payers (4.9%). Lower than average of industry peers (5.0%).Price Target Changed • Jun 14Price target decreased to RM4.12Down from RM4.58, the current price target is an average from 7 analysts. New target price is 16% above last closing price of RM3.55. Stock is down 16% over the past year. The company is forecast to post earnings per share of RM0.27 for next year compared to RM0.29 last year.Reported Earnings • Jun 14Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.071 in 3Q 2021)Third quarter 2022 results: EPS: RM0.057 (down from RM0.071 in 3Q 2021). Revenue: RM993.8m (up 1.7% from 3Q 2021). Net income: RM88.3m (down 20% from 3Q 2021). Profit margin: 8.9% (down from 11% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 17%, compared to a 24% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.お知らせ • Jun 13Scientex Berhad Declares Single Tier Interim Dividend for the Financial Year Ending July 31, 2022, Payable on July 22, 2022The Board of Directors of Scientex Berhad, in respect of the financial year ending 31 July 2022 declared a single tier interim dividend of MY 0.04 per ordinary share payable on July 22, 2022. Ex-Date: 07 July 2022. Entitlement date: 08 July 2022.分析記事 • Apr 28Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Richard Wong was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Major Estimate Revision • Mar 23Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from RM4.25b to RM4.11b. EPS estimate also fell from RM0.32 per share to RM0.28 per share. Net income forecast to grow 8.9% next year vs 23% growth forecast for Chemicals industry in Malaysia. Consensus price target down from RM4.97 to RM4.58. Share price rose 3.6% to RM4.07 over the past week.Reported Earnings • Mar 17Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: RM0.06 (down from RM0.072 in 2Q 2021). Revenue: RM952.0m (up 5.0% from 2Q 2021). Net income: RM93.7m (down 17% from 2Q 2021). Profit margin: 9.8% (down from 12% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 17%, compared to a 25% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 12% per year.分析記事 • Mar 09Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 46% Undervaluation?In this article we are going to estimate the intrinsic value of Scientex Berhad ( KLSE:SCIENTX ) by estimating the...Upcoming Dividend • Dec 28Upcoming dividend of RM0.05 per shareEligible shareholders must have bought the stock before 04 January 2022. Payment date: 13 January 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Malaysian dividend payers (4.5%). Lower than average of industry peers (3.3%).分析記事 • Dec 09These 4 Measures Indicate That Scientex Berhad (KLSE:SCIENTX) Is Using Debt Reasonably WellSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Nov 12Full year 2021 earnings released: EPS RM0.29 (vs RM0.25 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM3.66b (up 3.9% from FY 2020). Net income: RM457.2m (up 17% from FY 2020). Profit margin: 13% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year and the company’s share price has also increased by 16% per year.分析記事 • Oct 21Calculating The Intrinsic Value Of Scientex Berhad (KLSE:SCIENTX)In this article we are going to estimate the intrinsic value of Scientex Berhad ( KLSE:SCIENTX ) by estimating the...Reported Earnings • Sep 30Full year 2021 earnings released: EPS RM0.29 (vs RM0.25 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM3.66b (up 3.9% from FY 2020). Net income: RM457.2m (up 17% from FY 2020). Profit margin: 13% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 17% per year.分析記事 • Sep 24Return Trends At Scientex Berhad (KLSE:SCIENTX) Aren't AppealingWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...収支内訳Scientex Berhad の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KLSE:SCIENTX 収益、費用、利益 ( )MYR Millions日付収益収益G+A経費研究開発費31 Jan 264,594556332031 Oct 254,563545332031 Jul 254,518531332030 Apr 254,493512290031 Jan 254,491519290031 Oct 244,479536290031 Jul 244,476545290030 Apr 244,379524288031 Jan 244,268504288031 Oct 234,154469288031 Jul 234,077438288030 Apr 234,117448286031 Jan 234,113427286031 Oct 224,087414286031 Jul 223,985410286030 Apr 223,844428258031 Jan 223,827449258031 Oct 213,782468258031 Jul 213,656457258030 Apr 213,640457236031 Jan 213,436416236031 Oct 203,443402236031 Jul 203,519390236030 Apr 203,503381213031 Jan 203,559385213031 Oct 193,411361213031 Jul 193,247334213030 Apr 193,029283167031 Jan 192,797272167031 Oct 182,661266167031 Jul 182,603285167030 Apr 182,528274164031 Jan 182,568279164031 Oct 172,523276164031 Jul 172,403256164030 Apr 172,318238163031 Jan 172,226233163031 Oct 162,185232163031 Jul 162,201241163030 Apr 162,092236122031 Jan 162,004217122031 Oct 151,921189122031 Jul 151,8021581220質の高い収益: SCIENTXは 高品質の収益 を持っています。利益率の向上: SCIENTXの現在の純利益率 (12.1%)は、昨年(11.6%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: SCIENTXの収益は過去 5 年間で年間5.5%増加しました。成長の加速: SCIENTXの過去 1 年間の収益成長率 ( 7.2% ) は、5 年間の平均 ( 年間5.5%を上回っています。収益対業界: SCIENTXの過去 1 年間の収益成長率 ( 7.2% ) はChemicals業界2.4%を上回りました。株主資本利益率高いROE: SCIENTXの 自己資本利益率 ( 13.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 11:03終値2026/05/21 00:00収益2026/01/31年間収益2025/07/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Scientex Berhad 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Jing Yuan LowAffin Hwang Investment Banknull nullBIMB Securities Sdn. BhdChris TongKenanga Research5 その他のアナリストを表示
Reported Earnings • Mar 14Second quarter 2026 earnings released: EPS: RM0.087 (vs RM0.08 in 2Q 2025)Second quarter 2026 results: EPS: RM0.087 (up from RM0.08 in 2Q 2025). Revenue: RM1.14b (up 2.8% from 2Q 2025). Net income: RM135.2m (up 9.1% from 2Q 2025). Profit margin: 12% (in line with 2Q 2025). Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 23Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 2.7%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Sep 18Full year 2025 earnings released: EPS: RM0.34 (vs RM0.35 in FY 2024)Full year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 19Third quarter 2025 earnings released: EPS: RM0.08 (vs RM0.084 in 3Q 2024)Third quarter 2025 results: EPS: RM0.08 (down from RM0.084 in 3Q 2024). Revenue: RM1.11b (flat on 3Q 2024). Net income: RM123.9m (down 5.1% from 3Q 2024). Profit margin: 11% (in line with 3Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 13Second quarter 2025 earnings released: EPS: RM0.08 (vs RM0.091 in 2Q 2024)Second quarter 2025 results: EPS: RM0.08 (down from RM0.091 in 2Q 2024). Revenue: RM1.11b (up 1.1% from 2Q 2024). Net income: RM123.9m (down 12% from 2Q 2024). Profit margin: 11% (down from 13% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 24Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
分析記事 • May 15Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of InvestorsThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Reported Earnings • Mar 14Second quarter 2026 earnings released: EPS: RM0.087 (vs RM0.08 in 2Q 2025)Second quarter 2026 results: EPS: RM0.087 (up from RM0.08 in 2Q 2025). Revenue: RM1.14b (up 2.8% from 2Q 2025). Net income: RM135.2m (up 9.1% from 2Q 2025). Profit margin: 12% (in line with 2Q 2025). Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Dec 31Upcoming dividend of RM0.06 per shareEligible shareholders must have bought the stock before 07 January 2026. Payment date: 23 January 2026. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of Malaysian dividend payers (5.5%). In line with average of industry peers (3.4%).
分析記事 • Dec 29Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the...
分析記事 • Dec 15Scientex Berhad's (KLSE:SCIENTX) Dividend Will Be MYR0.06Scientex Berhad ( KLSE:SCIENTX ) will pay a dividend of MYR0.06 on the 23rd of January. This payment means that the...
Reported Earnings • Nov 23Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 2.7%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
分析記事 • Nov 17Scientex Berhad's (KLSE:SCIENTX) Dividend Will Be MYR0.06Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the 23rd of January...
お知らせ • Nov 17Scientex Berhad, Annual General Meeting, Dec 17, 2025Scientex Berhad, Annual General Meeting, Dec 17, 2025, at 11:30 Singapore Standard Time. Location: scientex packaging film sdn bhd, lot 4, jalan sungai pinang 4/3, seksyen 4, taman perindustrian pulau indah, 42920 pelabuhan klang, selangor darul ehsan, Malaysia
分析記事 • Sep 19Scientex Berhad (KLSE:SCIENTX) Is Due To Pay A Dividend Of MYR0.06Scientex Berhad ( KLSE:SCIENTX ) will pay a dividend of MYR0.06 on the 23rd of January. This payment means that the...
Declared Dividend • Sep 19Final dividend of RM0.06 announcedDividend of RM0.06 is the same as last year. Ex-date: 7th January 2026 Payment date: 23rd January 2026 Dividend yield will be 3.4%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 21% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
分析記事 • Sep 18Investors Could Be Concerned With Scientex Berhad's (KLSE:SCIENTX) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Reported Earnings • Sep 18Full year 2025 earnings released: EPS: RM0.34 (vs RM0.35 in FY 2024)Full year 2025 results: EPS: RM0.34 (down from RM0.35 in FY 2024). Revenue: RM4.52b (flat on FY 2024). Net income: RM530.8m (down 2.7% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • Sep 18+ 1 more updateScientex Berhad Appoints Puan Sabarina Binti Harun as Independent and Non Executive Independent Director, Effective September 17, 2025Scientex Berhad announced the appointment of PUAN SABARINA BINTI HARUN as Independent and Non Executive Independent Director. Age 48, date of change September 17, 2025. Qualifications Others Finance and Accounting Universiti Geomatika Malaysia Adjunct Professor Professional Qualification Accounting ASEAN Chartered Professional Accountant Professional Qualification Project Management Professional Project Management Institute Professional Qualification Accounting Malaysian Institute of Accountants Chartered Accountant (CA) Professional Qualification Accounting Certified Practising Accountant (CPA) Australia Fellow CPA (FCPA) Degree Bachelor of Commerce La Trobe University, Australia Working experience and occupation Mrs. Sabarina Binti Harun has more than twenty-five (25) years of experience in strategy development, financial management, digital transformation and operations. She has solid change management experience in her various positions, proven track record in managing cross-functional teams, implementing successful, robust and efficient operational processes for organisational change. Prior to joining SIRIM Berhad, Mrs. Sabarina was the Group Financial Controller to Inai Kiara Group of Companies, which is the fifth largest dredging company in the world. She started her career with Inai Kiara as the Financial Controller for the holding company, orchestrating a prominent impact in three (3) different portfolios namely finance, quality management and project management. She then joined SIRIM Berhad as the Group Chief Finance Officer to spearhead the overall financial operations, growth and strategies, asset management and procurement activities of SIRIM Berhad and its subsidiaries ("SIRIM Group"). She is currently the Group Chief Operating Officer at SIRIM Berhad, leading the Project Monitoring Office and Digital Services for SIRIM Group, overseeing the asset management and operations of ten (10) State offices nationwide and lead two (2) Strategic Business Units of SIRIM Group under the developmental and commercial mandates. Presently, she sits on the Board of Directors of Redtone Digital Berhad and DSR Taiko Berhad as an Independent Non-Executive Director. She is also a member of the Audit Committee and Nomination Committee of Redtone Digital Berhad; and Chairperson of the Audit Committee of DSR Taiko Berhad.
分析記事 • Jul 21Earnings Working Against Scientex Berhad's (KLSE:SCIENTX) Share PriceScientex Berhad's ( KLSE:SCIENTX ) price-to-earnings (or "P/E") ratio of 9.5x might make it look like a buy right now...
分析記事 • Jun 20Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.06Scientex Berhad's ( KLSE:SCIENTX ) investors are due to receive a payment of MYR0.06 per share on 18th of July. This...
Declared Dividend • Jun 20Dividend of RM0.06 announcedDividend of RM0.06 is the same as last year. Ex-date: 7th July 2025 Payment date: 18th July 2025 Dividend yield will be 3.5%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (34% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 17% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 19Scientex Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 31 July 2025, Payable on 18 July 2025In respect of the financial year ending 31 July 2025, the Board of Directors of Scientex Berhad declared a single tier interim dividend of 6 sen per ordinary share (single tier interim dividend for financial year 2024 of 6 sen per ordinary share), payable on 18 July 2025.
New Risk • Jun 19New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 44% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (44% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Reported Earnings • Jun 19Third quarter 2025 earnings released: EPS: RM0.08 (vs RM0.084 in 3Q 2024)Third quarter 2025 results: EPS: RM0.08 (down from RM0.084 in 3Q 2024). Revenue: RM1.11b (flat on 3Q 2024). Net income: RM123.9m (down 5.1% from 3Q 2024). Profit margin: 11% (in line with 3Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
分析記事 • May 23Scientex Berhad (KLSE:SCIENTX) Could Be Struggling To Allocate CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
分析記事 • Apr 29We Think Scientex Berhad (KLSE:SCIENTX) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Apr 02Improved Earnings Required Before Scientex Berhad (KLSE:SCIENTX) Shares Find Their FeetWhen close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") above 15x, you may consider...
Price Target Changed • Mar 13Price target decreased by 9.8% to RM4.19Down from RM4.65, the current price target is an average from 7 analysts. New target price is 19% above last closing price of RM3.53. Stock is down 8.5% over the past year. The company is forecast to post earnings per share of RM0.35 for next year compared to RM0.35 last year.
Reported Earnings • Mar 13Second quarter 2025 earnings released: EPS: RM0.08 (vs RM0.091 in 2Q 2024)Second quarter 2025 results: EPS: RM0.08 (down from RM0.091 in 2Q 2024). Revenue: RM1.11b (up 1.1% from 2Q 2024). Net income: RM123.9m (down 12% from 2Q 2024). Profit margin: 11% (down from 13% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Mar 12+ 4 more updatesScientex Berhad Announces Redesignation of Lim Peng Cheong as Chairman from Non-Independent DirectorScientex Berhad announced redesignation of Mr. Lim Peng Cheong as Chairman from Non-Independent Director. Age is 62 years. Directorate is Non Independent and Non Executive. Date of change is 12 March 2025. He did Bachelor of Science (Honours) in Business Studies from City University, UK. Working experience and occupation includes Mr. Lim Peng Cheong was appointed to the Board of Scientex Berhad as an Executive Director on 9 September 1988, and has held this position until 10 November 2003, when he was re-designated as Non-Executive Director. He was the Managing Director of Malacca Securities Sdn Bhd and was re-designated as Executive Chairman on 1 August 2021.
分析記事 • Jan 15Calculating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)Key Insights Scientex Berhad's estimated fair value is RM4.19 based on 2 Stage Free Cash Flow to Equity With RM4.01...
分析記事 • Jan 02Investors Met With Slowing Returns on Capital At Scientex Berhad (KLSE:SCIENTX)If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Upcoming Dividend • Dec 31Upcoming dividend of RM0.06 per shareEligible shareholders must have bought the stock before 07 January 2025. Payment date: 17 January 2025. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of Malaysian dividend payers (5.1%). Higher than average of industry peers (2.2%).
分析記事 • Dec 17Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.06 per share on the...
分析記事 • Nov 25Is Scientex Berhad (KLSE:SCIENTX) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Nov 24Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Nov 18Scientex Berhad, Annual General Meeting, Dec 18, 2024Scientex Berhad, Annual General Meeting, Dec 18, 2024, at 11:30 Singapore Standard Time.
分析記事 • Nov 05We Ran A Stock Scan For Earnings Growth And Scientex Berhad (KLSE:SCIENTX) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 • Sep 30Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06Scientex Berhad's ( KLSE:SCIENTX ) investors are due to receive a payment of MYR0.06 per share on 17th of January. This...
分析記事 • Sep 26Analysts Are Updating Their Scientex Berhad (KLSE:SCIENTX) Estimates After Its Annual ResultsIt's been a good week for Scientex Berhad ( KLSE:SCIENTX ) shareholders, because the company has just released its...
Declared Dividend • Sep 26Final dividend of RM0.06 announcedShareholders will receive a dividend of RM0.06. Ex-date: 7th January 2025 Payment date: 17th January 2025 Dividend yield will be 2.8%, which is lower than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (24% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Sep 25Full year 2024 earnings released: EPS: RM0.35 (vs RM0.28 in FY 2023)Full year 2024 results: EPS: RM0.35 (up from RM0.28 in FY 2023). Revenue: RM4.48b (up 9.8% from FY 2023). Net income: RM545.2m (up 24% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
分析記事 • Sep 09Scientex Berhad (KLSE:SCIENTX) Is Looking To Continue Growing Its Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
分析記事 • Aug 06Scientex Berhad (KLSE:SCIENTX) Ticks All The Boxes When It Comes To Earnings GrowthFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 • Jun 25Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts ThinkScientex Berhad ( KLSE:SCIENTX ) came out with its first-quarter results last week, and we wanted to see how the...
Price Target Changed • Jun 25Price target increased by 8.3% to RM4.51Up from RM4.16, the current price target is an average from 7 analysts. New target price is 5.8% above last closing price of RM4.26. Stock is up 26% over the past year. The company is forecast to post earnings per share of RM0.35 for next year compared to RM0.28 last year.
分析記事 • Jun 24Scientex Berhad (KLSE:SCIENTX) Is Increasing Its Dividend To MYR0.06The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will be paying its dividend of MYR0.06 on the 19th...
Declared Dividend • Jun 24Dividend increased to RM0.06Dividend of RM0.06 is 20% higher than last year. Ex-date: 9th July 2024 Payment date: 19th July 2024 Dividend yield will be 2.6%, which is lower than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 18% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Jun 22Third quarter 2024 earnings released: EPS: RM0.084 (vs RM0.071 in 3Q 2023)Third quarter 2024 results: EPS: RM0.084 (up from RM0.071 in 3Q 2023). Revenue: RM1.11b (up 11% from 3Q 2023). Net income: RM130.5m (up 19% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.
お知らせ • Jun 21Scientex Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 31 July 2024, Payable on 19 July 2024Scientex Berhad announced Single Tier Interim Dividend of 6 sen per ordinary share, for the Financial Year Ending 31 July 2024. Ex-Date: 09 July 2024; Entitlement date: 10 July 2024. Payment Date: 19 July 2024.
分析記事 • Mar 28Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen NextInvestors in Scientex Berhad ( KLSE:SCIENTX ) had a good week, as its shares rose 8.1% to close at RM4.13 following the...
分析記事 • Mar 27Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of InvestorsIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Mar 27Second quarter 2024 earnings released: EPS: RM0.091 (vs RM0.069 in 2Q 2023)Second quarter 2024 results: EPS: RM0.091 (up from RM0.069 in 2Q 2023). Revenue: RM1.09b (up 12% from 2Q 2023). Net income: RM141.0m (up 33% from 2Q 2023). Profit margin: 13% (up from 11% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 1% per year.
Upcoming Dividend • Dec 26Upcoming dividend of RM0.05 per share at 0.3% yieldEligible shareholders must have bought the stock before 02 January 2024. Payment date: 26 January 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (2.9%).
お知らせ • Dec 14+ 4 more updatesScientex Berhad Appoints Chin Lam Choong as Independent and Non Executive Chairman of Nomination and Remuneration Committee and Member of Audit Committee and Risk CommitteeScientex Berhad announced the appointment of Mr. Chin Lam Choong as Independent and Non Executive Chairman of Nomination and Remuneration Committee and Member of Audit Committee and Risk Committee of the company. Age: 57. Date of change: December 14, 2023. Composition of Audit Committee (Name and Directorate of members after change): change): Mr. Wong Chin Mun (Senior Independent Non-Executive Director) – Chairman; Dato' Noorizah Binti Hj Abd Hamid (Independent Non-Executive Director) – Member; Mr. Chin Lam Choong (Independent Non-Executive Director) – Member. Composition of Nomination and Remuneration Committee (Name and Directorate of members after change): Mr. Chin Lam Choong (Independent Non-Executive Director) - Chairman; Mr. Wong Chin Mun (Senior Independent Non-Executive Director) - Member; Mr. Lim Peng Cheong (Non-Independent Non-Executive Director) - Member. Composition of Risk Committee (Name and Directorate of members after change): Dato' Noorizah Binti Hj Abd Hamid (Independent Non-Executive Director) - Chairperson; Mr. Lim Peng Jin (Managing Director/Chief Executive Officer) - Member; Mr. Chin Lam Choong (Independent Non-Executive Director) - Member.
Reported Earnings • Nov 17Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: RM0.28 (up from RM0.26 in FY 2022). Revenue: RM4.08b (up 2.3% from FY 2022). Net income: RM438.1m (up 6.9% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 5.8%. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 4% per year.
お知らせ • Nov 15Scientex Berhad, Annual General Meeting, Dec 14, 2023Scientex Berhad, Annual General Meeting, Dec 14, 2023, at 11:30 Singapore Standard Time. Location: Auditorium, Bangunan Scientex, No. 9, Persiaran Selangor, Seksyen 15, 40200 Shah Alam Darul Ehsan Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 July 2023 together with the Reports of the Directors and Auditors thereon; to declare a single tier final dividend of 5 sen per ordinary share in respect of the financial year ended 31 July 2023; to re-elect Chin Lam Choong who retire by rotation in accordance with Regulation 87 of the Company's Constitution and being eligible, has offered himself for re-election; and to consider other matters.
分析記事 • Sep 23An Intrinsic Calculation For Scientex Berhad (KLSE:SCIENTX) Suggests It's 30% UndervaluedKey Insights The projected fair value for Scientex Berhad is RM5.35 based on 2 Stage Free Cash Flow to Equity Scientex...
分析記事 • Sep 22Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.05 per share on the...
お知らせ • Sep 21Scientex Berhad Declares A Single Tier Final Dividend for the Financial Ended July 31, 2023, Payable on January 26, 2024Scientex Berhad declared a single tier final dividend of MYR 0.0500 per ordinary share for the Financial ended July 31, 2023, payable on January 26, 2024. Ex-Date: January 2, 2024. Entitlement date: January 2, 2024.
Reported Earnings • Sep 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: RM0.28 (up from RM0.26 in FY 2022). Revenue: RM4.08b (up 2.3% from FY 2022). Net income: RM438.1m (up 6.9% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 5.8%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.
Upcoming Dividend • Jun 28Upcoming dividend of RM0.05 per share at 2.9% yieldEligible shareholders must have bought the stock before 05 July 2023. Payment date: 21 July 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Malaysian dividend payers (5.5%). Lower than average of industry peers (6.3%).
分析記事 • Jun 26Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Larger Dividend Than Last YearScientex Berhad ( KLSE:SCIENTX ) has announced that it will be increasing its dividend from last year's comparable...
Reported Earnings • Jun 21Third quarter 2023 earnings released: EPS: RM0.071 (vs RM0.057 in 3Q 2022)Third quarter 2023 results: EPS: RM0.071 (up from RM0.057 in 3Q 2022). Revenue: RM997.1m (flat on 3Q 2022). Net income: RM109.8m (up 24% from 3Q 2022). Profit margin: 11% (up from 8.9% in 3Q 2022). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 4% per year.
分析記事 • May 11Estimating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)Key Insights Scientex Berhad's estimated fair value is RM3.90 based on 2 Stage Free Cash Flow to Equity Scientex...
Reported Earnings • Mar 16Second quarter 2023 earnings released: EPS: RM0.069 (vs RM0.06 in 2Q 2022)Second quarter 2023 results: EPS: RM0.069 (up from RM0.06 in 2Q 2022). Revenue: RM978.4m (up 2.8% from 2Q 2022). Net income: RM106.3m (up 14% from 2Q 2022). Profit margin: 11% (up from 9.8% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 01Scientex Berhad Appoints Chua Siew Chuan as Joint Secretary, Effective February 1, 2023Scientex Berhad announced the appointment of Chua Siew Chuan as Joint Secretary of the company, with effect from February 1, 2023.
分析記事 • Jan 27Scientex Berhad (KLSE:SCIENTX) May Have Issues Allocating Its CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Upcoming Dividend • Dec 16Upcoming dividend of RM0.05 per shareEligible shareholders must have bought the stock before 23 December 2022. Payment date: 09 January 2023. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (5.7%).
Reported Earnings • Dec 10First quarter 2023 earnings released: EPS: RM0.069 (vs RM0.066 in 1Q 2022)First quarter 2023 results: EPS: RM0.069 (up from RM0.066 in 1Q 2022). Revenue: RM1.03b (up 11% from 1Q 2022). Net income: RM107.2m (up 4.2% from 1Q 2022). Profit margin: 10% (in line with 1Q 2022). Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.
分析記事 • Dec 09Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend of MYR0.05 per share on the 9th...
お知らせ • Dec 09Scientex Berhad Approves the Declaration of Single Tier Final DividendScientex Berhad approved the declaration of a single tier final dividend of 5 sen per ordinary share, at its AGM held on 8 December 2022.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Richard Wong was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 10Scientex Berhad, Annual General Meeting, Dec 08, 2022Scientex Berhad, Annual General Meeting, Dec 08, 2022, at 11:30 Singapore Standard Time. Location: Auditorium, Bangunan Scientex, No. 9, Persiaran Selangor, Seksyen 15 Shah Alam Selangor Malaysia Agenda: To approve the declaration of a single tier final dividend of 5 sen per ordinary share; to consider re-election of directors; to re-appoint Deloitte PLT as the Auditors of the Company and to authorise the Directors to fix their remuneration; and to consider other matters.
分析記事 • Oct 02Scientex Berhad (KLSE:SCIENTX) Has Affirmed Its Dividend Of MYR0.05The board of Scientex Berhad ( KLSE:SCIENTX ) has announced that it will pay a dividend on the 9th of January, with...
Reported Earnings • Sep 30Full year 2022 earnings released: EPS: RM0.26 (vs RM0.29 in FY 2021)Full year 2022 results: EPS: RM0.26 (down from RM0.29 in FY 2021). Revenue: RM3.99b (up 9.0% from FY 2021). Net income: RM409.9m (down 10% from FY 2021). Profit margin: 10% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Malaysia are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Sep 29Scientex Berhad Declares Single Tier Final Dividend for the Financial Ended July 31, 2022, Payable on January 09, 2023Scientex Berhad declared a single tier final dividend of MYR 0.0500 per ordinary share for the Financial ended July 31, 2022, payable on January 09, 2023. Ex-Date: December 23, 2022. Entitlement date: December 27, 2022.
分析記事 • Sep 23Scientex Berhad (KLSE:SCIENTX) Shares Could Be 35% Below Their Intrinsic Value EstimateHow far off is Scientex Berhad ( KLSE:SCIENTX ) from its intrinsic value? Using the most recent financial data, we'll...
分析記事 • Sep 08Here's Why Scientex Berhad (KLSE:SCIENTX) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
分析記事 • Jul 13Here's What's Concerning About Scientex Berhad's (KLSE:SCIENTX) Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Upcoming Dividend • Jun 30Upcoming dividend of RM0.04 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 22 July 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Malaysian dividend payers (4.9%). Lower than average of industry peers (5.0%).
Price Target Changed • Jun 14Price target decreased to RM4.12Down from RM4.58, the current price target is an average from 7 analysts. New target price is 16% above last closing price of RM3.55. Stock is down 16% over the past year. The company is forecast to post earnings per share of RM0.27 for next year compared to RM0.29 last year.
Reported Earnings • Jun 14Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.071 in 3Q 2021)Third quarter 2022 results: EPS: RM0.057 (down from RM0.071 in 3Q 2021). Revenue: RM993.8m (up 1.7% from 3Q 2021). Net income: RM88.3m (down 20% from 3Q 2021). Profit margin: 8.9% (down from 11% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 17%, compared to a 24% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 8% per year.
お知らせ • Jun 13Scientex Berhad Declares Single Tier Interim Dividend for the Financial Year Ending July 31, 2022, Payable on July 22, 2022The Board of Directors of Scientex Berhad, in respect of the financial year ending 31 July 2022 declared a single tier interim dividend of MY 0.04 per ordinary share payable on July 22, 2022. Ex-Date: 07 July 2022. Entitlement date: 08 July 2022.
分析記事 • Apr 28Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Richard Wong was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Major Estimate Revision • Mar 23Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from RM4.25b to RM4.11b. EPS estimate also fell from RM0.32 per share to RM0.28 per share. Net income forecast to grow 8.9% next year vs 23% growth forecast for Chemicals industry in Malaysia. Consensus price target down from RM4.97 to RM4.58. Share price rose 3.6% to RM4.07 over the past week.
Reported Earnings • Mar 17Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: RM0.06 (down from RM0.072 in 2Q 2021). Revenue: RM952.0m (up 5.0% from 2Q 2021). Net income: RM93.7m (down 17% from 2Q 2021). Profit margin: 9.8% (down from 12% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 17%, compared to a 25% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 12% per year.
分析記事 • Mar 09Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 46% Undervaluation?In this article we are going to estimate the intrinsic value of Scientex Berhad ( KLSE:SCIENTX ) by estimating the...
Upcoming Dividend • Dec 28Upcoming dividend of RM0.05 per shareEligible shareholders must have bought the stock before 04 January 2022. Payment date: 13 January 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Malaysian dividend payers (4.5%). Lower than average of industry peers (3.3%).
分析記事 • Dec 09These 4 Measures Indicate That Scientex Berhad (KLSE:SCIENTX) Is Using Debt Reasonably WellSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Nov 12Full year 2021 earnings released: EPS RM0.29 (vs RM0.25 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM3.66b (up 3.9% from FY 2020). Net income: RM457.2m (up 17% from FY 2020). Profit margin: 13% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year and the company’s share price has also increased by 16% per year.
分析記事 • Oct 21Calculating The Intrinsic Value Of Scientex Berhad (KLSE:SCIENTX)In this article we are going to estimate the intrinsic value of Scientex Berhad ( KLSE:SCIENTX ) by estimating the...
Reported Earnings • Sep 30Full year 2021 earnings released: EPS RM0.29 (vs RM0.25 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM3.66b (up 3.9% from FY 2020). Net income: RM457.2m (up 17% from FY 2020). Profit margin: 13% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 17% per year.
分析記事 • Sep 24Return Trends At Scientex Berhad (KLSE:SCIENTX) Aren't AppealingWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...